What they're not telling you: # De-pushes-forward-multiple.html" title="De-Extinct Dire Wolves Ready To Breed; Bioscience Company Pushes Forward Multiple Projects" style="color:#1a1a1a;text-decoration:underline;text-decoration-style:dotted;font-weight:500;">Extinct Dire Wolves Ready To Breed; Bioscience Company Pushes Forward Multiple Projects A Texas biotech firm has successfully bred the first de-extinct animals on Earth and plans to expand their pack this year, marking a watershed moment for genetic engineering that mainstream outlets have largely overlooked. Colossal Biosciences announced that three dire wolves—Romulus, Remus, and Khaleesi—born in late 2024 and early 2025, have reached breeding age on a 2,000-acre preserve. The animals, reconstructed from 72,000-year-old DNA fragments, represent not merely a scientific curiosity but a functional proof of concept that extinct species can be brought back and sustained as living populations.
# THE TAKE: Pleistocene Vanity Project Masks Real Extinction Crisis Colossal Biosciences isn't resurrecting dire wolves. It's monetizing nostalgia while actual species vanish unnoticed. The math doesn't work: billions spent engineering extinct apex predators versus pennies protecting habitat for living megafauna already circling extinction drains. This isn't science—it's billionaire-backed spectacle masquerading as conservation. Here's the play: Create headline-grabbing "de-extinction" while ecosystems collapse from industrial agriculture, deforestation, and climate collapse. Dire wolves need *ecosystem infrastructure* we've demolished. You can't rewild a Pleistocene predator into a 2025 monoculture hellscape. The real tell? Colossal's funding comes from biotech venture capital seeking exit strategies, not from organizations solving *actual* extinction prevention. They're not saving species. They're selling a fantasy that technology absolves us from protecting what still survives. De-extinction theater while we're orchestrating the sixth mass extinction. The wolves aren't the problem. Our priorities are.
What the Documents Show
Matt James, Colossal's chief animal officer, confirmed the wolves are capable of natural reproduction, though the company plans to engineer two to four additional pups first to maximize genetic diversity before allowing full natural breeding. The dire wolves were created by extracting genetic material from ancient bone samples and editing gray wolf embryos to incorporate extinct traits: a white coat, larger teeth, a more muscular build, and a distinctive howl. Embryos were then implanted in surrogate dogs. The fact that three pups survived birth and have now thrived for months in a semi-wild habitat demonstrates that de-extinction engineering can produce animals viable enough to exhibit natural behaviors—learning to process whole deer carcasses and displaying mating readiness—rather than producing sterile laboratory specimens. What the mainstream framing misses is the precedent this sets for capital investment in genetic resurrection.
Follow the Money
Colossal isn't operating in isolation; it has announced multiple de-extinction projects beyond dire wolves. CEO Ben Lamm stated the company expects more pups "by the end of the year," signaling confidence in scaling the technology. The company's ability to fund, execute, and successfully breed engineered animals suggests that de-extinction isn't a one-time stunt but an emerging commercial industry. The 2,000-acre secure preserve indicates infrastructure now exists to contain and monitor de-extinct populations in real time. The broader implication for ordinary people extends beyond spectacle. If de-extinction becomes routine, questions about ecosystem management, liability, intellectual property ownership of resurrected genomes, and regulatory oversight remain almost entirely unexamined in public discourse.
What Else We Know
A sustainable population of dire wolves—engineered predators with traits selected by humans—introduces novel variables into ecological systems and wildlife policy. The technology's expansion also raises questions about which species deserve resurrection and who decides. Colossal's success with dire wolves will likely prompt competing biotech firms to pursue their own de-extinction projects, creating a landscape where ancient species are brought back not primarily for conservation but for market viability and shareholder return. The emergence of viable de-extinct breeding populations represents a genuine inflection point in biotechnology, yet it has generated minimal mainstream scrutiny of its long-term implications. Colossal's announcement should prompt serious inquiry into how societies will manage, regulate, and ethically deploy resurrection technology at scale.
Primary Sources
- Source: ZeroHedge
- Category: Money & Markets
- Cross-reference independently — don't take our word for it.
Disclosure: NewsAnarchist aggregates from public records, API feeds (Federal Register, CourtListener, MuckRock, Hacker News), and independent media. AI-assisted synthesis. Always verify primary sources linked above.